UCLA Ventura Cardiology is a clinical research site located in Ventura, California, United States 93003.
Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.
UCLA Ventura Cardiology has participated in 2 clinical trials with 2 currently active.
Therapeutic areas: Urothelial Carcinoma.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer.
Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UCLA Ventura Cardiology has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UCLA Ventura Cardiology has 2 clinical trials on record, with 2 currently active. Their work covers Urothelial Carcinoma.
UCLA Ventura Cardiology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.